ArticleFrontiers in digital health2026
High-technology telerehabilitation for the treatment of frail and pre-frail patients: the TeleRiab4FRA study design and protocol.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07561021 (High-technology TeleRehabilitation for the Treatment of the FRAgile Patient), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
High-technology TeleRehabilitation for the Treatment of the FRAgile Patient
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic heart failure (CHF) in older adults is frequently associated with frailty, reduced functional capacity, cognitive vulnerability, poor quality of life, and recurrent healthcare needs. Despite the recognized benefits of cardiac rehabilitation, access and adherence to conventional center-based programs remain suboptimal in frail and pre-frail patients. The TeleRiab4FRA study investigates whether an 8-week high-technology telerehabilitation program combining sensorimotor and cognitive training can improve functional capacity and multidimensional outcomes in frail and pre-frail older adults with CHF. Methods: TeleRiab4FRA is a randomized, controlled, prospective, monocentric, parallel-group, open-label, non-profit clinical trial enrolling approximately 80 patients aged ≥65 years with stable CHF, New York Heart Association functional class I-III, and documented frailty or pre-frailty. Participants are randomized in a 1:1 ratio to a telerehabilitation group or to a caregiver-supervised home-based rehabilitation group. The telerehabilitation intervention is delivered through a synchronous digital platform using CE-marked devices for remote monitoring of electrocardiographic tracing, heart rate, peripheral oxygen saturation, and blood pressure. Both groups receive an 8-week individualized program including motor and cognitive training tailored according to frailty status. Assessments are performed at baseline, 4 weeks, 8 weeks, 16 weeks, and 24 weeks. The primary endpoint is the change in peak oxygen uptake (VO₂peak) measured by cardiopulmonary exercise testing from baseline to 8 weeks. Secondary outcomes include frailty status assessed by the Italian Frailty Index, physical performance, cognitive function, health-related quality of life, adherence, caregiver burden, perceived stress, technological usability, biomarkers, and safety events. Expected results: We hypothesize that high-technology telerehabilitation will lead to greater improvement in functional capacity than caregiver-supervised home-based rehabilitation. We further hypothesize favorable effects on frailty status, physical performance, cognitive outcomes, adherence, usability, and safety, with maintenance of any functional benefits at the 24-week follow-up. These statements represent prespecified hypotheses and not study findings. Conclusion: TeleRiab4FRA is designed to evaluate the clinical utility, feasibility, and safety of a synchronous, technology-enabled telerehabilitation model for frail and pre-frail older adults with CHF. If effective, this approach may support the development of scalable, personalized, and patient-centered rehabilitation pathways integrating clinical supervision, digital monitoring, and home-based care. Clinical trial registration: ClinicalTrials.gov, identifier NCT07561021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.